Sulfated glycosaminoglycans in protein ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
Sulfated glycosaminoglycans in protein aggregation diseases
Auteur(s) :
Titre de la revue :
Glycoconjugate journal
Nom court de la revue :
Glycoconj. J.
Numéro :
34
Pagination :
453-466
Date de publication :
2017
ISSN :
1573-4986
Mot(s)-clé(s) en anglais :
Heparan sulfate
Protein Aggregates
Protein aggregation disease
Animals
Glycosaminoglycans
Disease
Humans
Cell Communication
Amyloidosis
Sulfates
Protein Aggregation, Pathological
Protein Aggregates
Protein aggregation disease
Animals
Glycosaminoglycans
Disease
Humans
Cell Communication
Amyloidosis
Sulfates
Protein Aggregation, Pathological
Discipline(s) HAL :
Chimie/Chimie théorique et/ou physique
Résumé en anglais : [en]
Protein aggregation diseases are characterized by intracellular or extracellular deposition of misfolded and aggregated proteins. These aggregated deposits contain multiple proteinaceous and non-protein components that are ...
Lire la suite >Protein aggregation diseases are characterized by intracellular or extracellular deposition of misfolded and aggregated proteins. These aggregated deposits contain multiple proteinaceous and non-protein components that are thought to play critical roles in the etiology and pathogenesis of protein aggregation diseases in vivo. One of these components, the sulfated glycosaminoglycans (GAGs), includes heparan sulfate, chondroitin sulfate, and keratan sulfate. The sulfated GAGs are negatively charged heteropolysaccharides expressed in all mammalian tissues. Enzymatically generated structural patterns and the degree of sulfation in GAGs determine GAGs' specific interactions with their protein ligands. Here, we review the potential roles of the sulfated GAGs in the pathogenesis and progression of protein aggregation diseases from a perspective of their sulfation modification. We also discuss the possibility of sulfated GAGs as therapeutic targets for protein aggregation diseases.Lire moins >
Lire la suite >Protein aggregation diseases are characterized by intracellular or extracellular deposition of misfolded and aggregated proteins. These aggregated deposits contain multiple proteinaceous and non-protein components that are thought to play critical roles in the etiology and pathogenesis of protein aggregation diseases in vivo. One of these components, the sulfated glycosaminoglycans (GAGs), includes heparan sulfate, chondroitin sulfate, and keratan sulfate. The sulfated GAGs are negatively charged heteropolysaccharides expressed in all mammalian tissues. Enzymatically generated structural patterns and the degree of sulfation in GAGs determine GAGs' specific interactions with their protein ligands. Here, we review the potential roles of the sulfated GAGs in the pathogenesis and progression of protein aggregation diseases from a perspective of their sulfation modification. We also discuss the possibility of sulfated GAGs as therapeutic targets for protein aggregation diseases.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CNRS
Université de Lille
Université de Lille
Collections :
Date de dépôt :
2020-02-12T15:11:32Z
2021-07-13T09:05:35Z
2021-07-13T09:05:35Z